Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction

Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy

(2012) Chantal Barthomeuf et al.   Anti-Cancer Agents in Medicinal Chemistry

Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

(2012) Jing Peng et al.   Anti-Cancer Agents in Medicinal Chemistry

XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells

(2011) Yan Liu et al.   APOPTOSIS

Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters

(2011) S. Shukla et al.   CURRENT DRUG TARGETS

The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells

(2010) Jie Yin et al.   ACTA PHARMACOLOGICA SINICA

Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification and therapeutic targets

(2010) Tamara Severi et al.   ACTA PHARMACOLOGICA SINICA

Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells

(2010) Ioana Abraham et al.   BIOCHEMICAL PHARMACOLOGY

Suppression of Signal Transducer and Activator of Transcription 3 Activation by Butein Inhibits Growth of Human Hepatocellular Carcinoma In Vivo

(2010) Peramaiyan Rajendran et al.   CLINICAL CANCER RESEARCH

Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?

(2010) M. Masuda et al.   CURRENT CANCER DRUG TARGETS

Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy

(2010) Elizabeth W LaPensee et al.   ENDOCRINE-RELATED CANCER

The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer

(2010) John T Isaacs   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

(2010) George V. Papatheodoridis et al.   JOURNAL OF HEPATOLOGY

Synthesis and antitumor evaluation of methyl spongoate analogs

(2010) Cheng-Shi Jiang et al.   STEROIDS

Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein

(2009) Steven Fletcher et al.   Biochemistry and Cell Biology

Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells

(2009) Pepita Gimenez-Bonafe et al.   CURRENT CANCER DRUG TARGETS

Molecular targeted therapy for hepatocellular carcinoma

(2009) Melanie Thomas   JOURNAL OF GASTROENTEROLOGY

Liver cancer stem cells: implications for a new therapeutic target

(2009) Terence Kin Wah Lee et al.   LIVER INTERNATIONAL

Structural and kinetic determinants of protease substrates

(2009) John C Timmer et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Bryostatin-5 Blocks Stromal Cell–Derived Factor-1 Induced Chemotaxis via Desensitization and Down-regulation of Cell Surface CXCR4 Receptors

(2008) Xing He et al.   CANCER RESEARCH

STAT3 as a target for inducing apoptosis in solid and hematological tumors

(2008) Khandaker Al Zaid Siddiquee et al.   CELL RESEARCH